130 related articles for article (PubMed ID: 19267103)
1. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
[TBL] [Abstract][Full Text] [Related]
2. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract][Full Text] [Related]
4. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
Verri C; Roz L; Conte D; Liloglou T; Livio A; Vesin A; Fabbri A; Andriani F; Brambilla C; Tavecchio L; Calarco G; Calabrò E; Mancini A; Tosi D; Bossi P; Field JK; Brambilla E; Sozzi G;
Am J Respir Crit Care Med; 2009 Mar; 179(5):396-401. PubMed ID: 19096006
[TBL] [Abstract][Full Text] [Related]
5. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
7. Importance of novel sequence alterations in the FHIT gene on formation of breast cancer.
Ceçener G; Egeli U; Tunca B; Taşdelen I; Tolunay S; Bilgel N
Tumori; 2007; 93(6):597-603. PubMed ID: 18338496
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
9. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.
Jung HY; Sung JS; Whang YM; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Sung HJ; Choi IK; Oh SC; Seo JH; Kim YH
J Hum Genet; 2007; 52(8):668. PubMed ID: 17609851
[TBL] [Abstract][Full Text] [Related]
12. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
13. Detection of FHIT and p16 mRNA deletion in biopsy specimens obtained by bronchoscopy for the diagnosis of lung cancer.
Chen P; Li J; Wang Y; Zhu LR; Hu YM; Tong XP
Int J Biol Markers; 2013 Sep; 28(3):259-66. PubMed ID: 23709347
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
15. Do FHIT gene alterations play a role in human solid tumors?
Silveira Zavalhia L; Weber Medeiros A; Oliveira Silva A; Vial Roehe A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e214-e223. PubMed ID: 29516675
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion.
Li J; Bao QL; Wang Y; Hu YM; Chen P
Cancer Biomark; 2013; 13(1):49-58. PubMed ID: 23736021
[TBL] [Abstract][Full Text] [Related]
17. FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme.
Cecener G; Tunca B; Egeli U; Bekar A; Guler G; Tolunay S; Aksoy K
Cell Mol Neurobiol; 2010 Mar; 30(2):301-7. PubMed ID: 19760177
[TBL] [Abstract][Full Text] [Related]
18. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer].
Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW
Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266
[TBL] [Abstract][Full Text] [Related]
19. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
20. FHIT gene abnormalities in both benign and malignant thyroid tumours.
Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
